loading
전일 마감가:
$18.71
열려 있는:
$18.67
하루 거래량:
15.81M
Relative Volume:
1.76
시가총액:
$10.17B
수익:
$10.89B
순이익/손실:
$-241.00M
주가수익비율:
-74.51
EPS:
-0.2656
순현금흐름:
$340.00M
1주 성능:
-8.93%
1개월 성능:
+0.71%
6개월 성능:
-17.92%
1년 성능:
-35.37%
1일 변동 폭
Value
$18.61
$20.13
1주일 범위
Value
$18.57
$22.41
52주 변동 폭
Value
$17.40
$37.74

박스터 인터내셔널 Stock (BAX) Company Profile

Name
명칭
Baxter International Inc
Name
전화
(224) 948-2000
Name
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
Name
직원
38,000
Name
트위터
@baxter_intl
Name
다음 수익 날짜
2024-11-08
Name
최신 SEC 제출 서류
Name
BAX's Discussions on Twitter

Compare BAX vs ISRG, BDX, ALC, MDLN, RMD

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Instruments & Supplies icon
BAX
Baxter International Inc
19.79 9.62B 10.89B -241.00M 340.00M -0.2656
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
485.84 169.97B 10.06B 2.88B 2.49B 7.876
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
175.89 50.58B 21.92B 1.76B 2.63B 6.1223
Medical Instruments & Supplies icon
ALC
Alcon Inc
79.20 38.58B 10.19B 1.05B 1.38B 2.1044
Medical Instruments & Supplies icon
MDLN
Medline Inc
44.55 37.11B 27.43B 1.27B 1.01B 1.5829
Medical Instruments & Supplies icon
RMD
Resmed Inc
252.55 35.80B 5.40B 1.49B 1.78B 10.12

박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-31 다운그레이드 Argus Buy → Hold
2025-08-04 다운그레이드 Stifel Buy → Hold
2025-08-01 다운그레이드 Goldman Buy → Neutral
2025-02-26 재개 Goldman Buy
2025-02-24 업그레이드 Argus Hold → Buy
2025-02-20 재개 Barclays Overweight
2024-07-15 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2024-05-30 개시 Goldman Neutral
2024-05-10 다운그레이드 TD Cowen Buy → Hold
2023-05-30 재개 Morgan Stanley Equal-Weight
2023-03-29 개시 UBS Neutral
2023-01-06 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-01-05 다운그레이드 Raymond James Outperform → Mkt Perform
2023-01-03 다운그레이드 BofA Securities Buy → Neutral
2022-12-19 다운그레이드 JP Morgan Overweight → Neutral
2022-12-15 다운그레이드 Deutsche Bank Buy → Hold
2022-12-12 다운그레이드 Citigroup Buy → Neutral
2022-10-18 개시 Barclays Overweight
2022-10-12 개시 Jefferies Hold
2022-06-24 다운그레이드 Wells Fargo Overweight → Equal Weight
2022-04-04 다운그레이드 Goldman Neutral → Sell
2022-03-02 재개 BofA Securities Buy
2022-02-18 재확인 KeyBanc Capital Markets Overweight
2022-02-18 재확인 Morgan Stanley Overweight
2022-02-18 재확인 Raymond James Outperform
2022-02-18 재확인 Stifel Buy
2022-02-18 재확인 UBS Neutral
2022-02-18 재확인 Wells Fargo Overweight
2022-02-11 개시 Goldman Neutral
2022-01-07 재개 Citigroup Buy
2022-01-07 업그레이드 Morgan Stanley Equal-Weight → Overweight
2021-09-13 업그레이드 Cowen Market Perform → Outperform
2021-09-03 업그레이드 Barclays Equal Weight → Overweight
2021-05-25 개시 Barclays Equal Weight
2021-01-29 다운그레이드 Piper Sandler Overweight → Neutral
2021-01-06 다운그레이드 UBS Buy → Neutral
2020-12-15 다운그레이드 Goldman Buy → Neutral
2020-10-01 업그레이드 Citigroup Neutral → Buy
2020-09-04 다운그레이드 Argus Buy → Hold
2020-06-24 개시 Oppenheimer Outperform
2020-03-19 업그레이드 Stifel Hold → Buy
2020-03-18 업그레이드 KeyBanc Capital Markets Sector Weight → Overweight
2020-03-05 개시 Citigroup Neutral
2020-02-13 개시 Goldman Buy
2020-01-02 업그레이드 Evercore ISI In-line → Outperform
2019-12-17 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2019-06-26 개시 KeyBanc Capital Markets Sector Weight
2019-04-08 다운그레이드 Evercore ISI Outperform → In-line
2019-01-02 업그레이드 Citigroup Neutral → Buy
2019-01-02 업그레이드 Morgan Stanley Underweight → Overweight
2018-11-02 업그레이드 Argus Hold → Buy
2018-10-16 개시 Barclays Underweight
2018-05-17 재개 Piper Jaffray Overweight
2018-02-06 재확인 Citigroup Neutral
2018-01-03 개시 Evercore ISI Outperform
2018-01-03 업그레이드 Raymond James Mkt Perform → Outperform
모두보기

박스터 인터내셔널 주식(BAX)의 최신 뉴스

pulisher
10:28 AM

Baxter International Inc.: How a 90-Year Medtech Veteran Is Rebuilding Its Product Playbook - AD HOC NEWS

10:28 AM
pulisher
12:59 PM

The Truth About Baxter International Inc.: Hidden Healthcare Giant or Total Snooze Stock? - AD HOC NEWS

12:59 PM
pulisher
12:27 PM

Baxter lays off 90 employees from hurricane-hit unit - Medical Buyer

12:27 PM
pulisher
Feb 13, 2026

Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch

Feb 13, 2026
pulisher
Feb 13, 2026

BAX Q4 Deep Dive: Mixed Segment Performance and Margin Pressures Shape Outlook - Finviz

Feb 13, 2026
pulisher
Feb 13, 2026

Looking Into Baxter International Inc's Recent Short Interest - Benzinga

Feb 13, 2026
pulisher
Feb 13, 2026

Barclays Lowers Price Target for Baxter Intl (BAX) While Maintai - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Baxter sales up 8% to USD 2.97B in Q4 2025 - Medical Buyer

Feb 13, 2026
pulisher
Feb 13, 2026

Baxter International Inc. (NYSE:BAX) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 13, 2026
pulisher
Feb 13, 2026

Baxter International Inc. (NYSE:BAX) Q4 2025 earnings call transcript - MSN

Feb 13, 2026
pulisher
Feb 13, 2026

Baxter's new CEO mired in damage control before he can address long-term problems - Crain's Chicago Business

Feb 13, 2026
pulisher
Feb 13, 2026

Baxter International Inc. stock underperforms Thursday when compared to competitors - MSN

Feb 13, 2026
pulisher
Feb 13, 2026

Baxter Stock (-16%): Profit Guidance Collapse Triggers De-Risking - Trefis

Feb 13, 2026
pulisher
Feb 13, 2026

Decoding Baxter International Inc (BAX): A Strategic SWOT Insigh - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Baxter International Is Quietly Going Off – But Is BAX Stock Really Worth Your Money? - AD HOC NEWS

Feb 13, 2026
pulisher
Feb 12, 2026

Baxter International (BAX) Q4 2025 Sales Exceed Expectations, EPS Falls Short - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter is the S&P 500’s worst performer today. Earnings were brutal. - MSN

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International Earnings Call: Growth Meets Margin Squeeze - TipRanks

Feb 12, 2026
pulisher
Feb 12, 2026

BAXTER INTERNATIONAL INC SEC 10-K Report - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International Inc (BAX) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Pressures - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter stock dives on Q4 EPS miss, company introduces new operating model - massdevice.com

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter (BAX) Q4 Earnings Miss, Revenue Surpasses Expectations - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International: Debt, Margin Pressure, Dreadful FY26 Guidance (Downgrade) (NYSE:BAX) - Seeking Alpha

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter shares tumble 16% on weak earnings - breakingthenews.net

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International Stock Falls Sharply. Earnings Were Brutal. - Barron's

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International Q4 Earnings Call Highlights - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Key facts: Baxter International appoints McDonnell; reports Q4 loss - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

Why Baxter International Stock Was Tumbling Today - AOL.com

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter Turnaround Efforts Continue, but Outcome Remains Uncertain - Morningstar

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter annual profit forecast disappoints as key product troubles mount - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

Why Baxter International Stock Was Tumbling Today - The Motley Fool

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter forecast 2026 profit below estimates - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter (BAX) Q4 2025 Earnings Call Transcript - The Globe and Mail

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter Shares Tank As 2026 Profit Guidance Falls Below Expectations - Bitget

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter Shares Tank, 2026 Profit Guidance Lower Than ExpectedBaxter Intl (NYSE:BAX) - Benzinga

Feb 12, 2026
pulisher
Feb 12, 2026

BAX Stock Falls Following Q4 Earnings Miss, Margins Contract - The Globe and Mail

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter Faces Legal Claims Amid Financial Uncertainty - StocksToTrade

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter CEO: ‘We need to get better’ - Modern Healthcare News

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International Faces Potential Legal Claims Amid Stock Concerns - timothysykes.com

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

Earnings call transcript: Baxter’s Q4 2025 results miss EPS forecast, stock drops By Investing.com - Investing.com India

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter slips following Q4 bottom line miss, weak 2026 EPS guidance - MSN

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter Q4 2025 slides: Revenue grows 8% but margins compress, EPS misses target By Investing.com - Investing.com India

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International (BAX) Sees Market Activity Rise - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Legal Concerns Loom Over Baxter Amid Fiduciary Duty Accusations - StocksToTrade

Feb 12, 2026
pulisher
Feb 12, 2026

Earnings call transcript: Baxter’s Q4 2025 results miss EPS forecast, stock drops - Investing.com

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter (BAX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Australia

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter Shares Plunge on Dismal Financial Outlook - AD HOC NEWS

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International (BAX) Q4 Earnings Lag Estimates - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter International Inc (NYSE:BAX) Stock Plummets on Q4 Earnings Miss and Weak 2026 Outlook - ChartMill

Feb 12, 2026
pulisher
Feb 12, 2026

Baxter: Q4 Earnings Snapshot - kens5.com

Feb 12, 2026

박스터 인터내셔널 (BAX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$75.55
price down icon 0.53%
$186.77
price up icon 1.58%
medical_instruments_supplies COO
$82.99
price up icon 1.58%
$75.04
price up icon 0.17%
medical_instruments_supplies WST
$250.49
price up icon 2.82%
medical_instruments_supplies RMD
$252.55
price up icon 2.78%
자본화:     |  볼륨(24시간):